
New fat jabs warning over ‘increased risk of cancer – as experts fear they ‘stop common medication working'
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
WEIGHT loss jabs could prevent a medication taken by millions of women from working - and increase patients' risk of cancer.
The British Menopause Society said the jabs could cause hormone imbalance in women taking hormone replacement therapy (HRT), particularly for those with obesity, putting them 'at increased risk of womb cancer'.
1
Women commonly take a progesterone pill along with oestrogen patches or cream
Credit: Getty
It follows warnings to women on weight loss medications to take effective contraception, as the jabs could render the pill less effective.
That's because weight loss drugs Wegovy and Mounjaro - as well as diabetes jab Ozempic - can delay the absorption of pills taken orally, as well slowing down the passage of food through the gut.
Guidance suggests women taking HRT in pill form may also be at risk.
The British Menopause Society (BMS) told doctors to closely monitor menopausal women on HRT who are also using weight-loss jabs.
The treatment tops up the hormones oestrogen and progesterone, which dip to low levels as the menopause approaches.
Data from 2023-24 showed that 2.6 million women in England rely on the drugs to alleviate hot flushes, night sweats, difficulty sleeping and mood changes.
"During the last two years, since semaglutide and tirzepatide [the active ingredients in Wegovy and Mounjaro] received licenses for weight loss, there has been an increase in uptake of these medications through private clinics, while NHS prescribing is limited to specialist weight management services," the BMS guidance stated.
"There are no current data available about numbers of women receiving HRT concurrently with semaglutide or tirzepatide."
The most common form of HRT is a progesterone pill alongside a skin patch or gel to deliver oestrogen, but some people opt for a combined pill.
Progesterone balances out the effects of oestrogen, which on its own stimulates the growth of the womb lining, and can cause 'abnormal cells and cancer' to grow.
Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies
The menopause experts expressed concern over the loss of the progesterone's protective effect on the womb as a result of weight loss jabs.
They recommended that doctors move women taking progesterone orally to an intrauterine device, such as a Mirena coil, or increase their dose of progesterone.
Prof Annice Mukherjee, a consultant endocrinologist and member of the society's medical advisory council, who led on the guidance, told The Telegraph that a hormone imbalance could put women 'at increased risk of womb cancer' - particularly if they are obese.
'Oestrogen is almost always given through the skin for HRT in women living with obesity, but progesterone is frequently given as a tablet, and that formulation is thought to be the safest route for women who have complicated health issues,' she said.
'If we then start one of these injectable weight-loss drugs, then you're preferentially stopping absorption of the progestogen that's coming in orally, but you're allowing plenty of the oestrogen through the skin.
'The rules are very clear that if you give a very high dose of oestrogen and you don't give enough progesterone, however that happens, you're putting that woman at risk of womb cancer,' she said.
Prof Mukherjee said there was currently a 'culture of putting women on very high doses of oestrogen', which can make the womb lining thicken.
'It's like having a lawn in a woman's womb. Oestrogen makes the lawn grow. Progestogen cuts the lawn. But if it's not being cut, it grows thicker, and then you can get abnormal cells and cancer.'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
But she also stressed that the biggest risk factor for womb cancer was obesity - meaning that on the whole, weight loss jabs can cut the risk of disease.
'These drugs reduce the risk of cancer,' Prof Mukherjee said.
'But if they are prescribed to a woman who's on oestrogen through the skin, and she might already have womb thickening because she's living with obesity, and she's not absorbing the progesterone because she's been put on a weight-loss injection, she's potentially getting loads of oestrogen on top of her thickened womb lining, and that could potentially unmask cancers that are there or drive an early cancer to a more advanced stage.'
The BMS put together the guidelines after calls from GPs for advice to give to patients.
Dr Janet Barter, the president of the Faculty of Sexual and Reproductive Healthcare, told The Telegraph that weight loss jabs can cause side effects such as "vomiting and severe diarrhoea in some patients'.
'Obviously this could render any medication, such as HRT tablets or oral contraception, ineffective if there hasn't been enough time for them to be fully absorbed,' she said.
'If these side-effects are occurring, then people should discuss the matter with their doctor or specialist clinician to find the combination of drugs that's right for them.'
Sun Health has contacted Novo Nordisk and Eli Lilly - the makers of Wegovy and Mounjaro - for comment.
It follows warnings from the Medicines and Healthcare products Agency (MHRA) that GLP-1 weight loss drugs could reduce the absorption of contraceptives, due to the fact they slow down the emptying of the stomach.
The watchdog also said the jabs should not be used during pregnancy, while trying to conceive or breastfeeding, over fears they could lead to miscarriage or birth defects.
The MHRA explained: 'This is because there is not enough safety data to know whether taking the medicine could cause harm to the baby.'
Dr Bassel Wattar, a consultant gynaecologist and medical director of clinical trials at Anglia Ruskin University, told The Sun: 'It's not the medication itself, but the weight loss that helps regulate a woman's hormones allowing her ovaries to function properly again.
'Pregnancy is more of a happy side effect.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
8 minutes ago
- Reuters
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial
June 9 (Reuters) - Shares of weight-loss drug developer Metsera (MTSR.O), opens new tab gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a monthly dosing regime. The drug developer, which went public in January, is one of the many that are eyeing the lucrative market of weight-loss drugs that have been dominated by GLP-1 drugs from Novo Nordisk ( opens new tab and Eli Lilly (LLY.N), opens new tab. The drug, MET-233i, helped patients lose 8.4% of their weight, when adjusted for placebo, at 36 weeks. The drug belongs to a class of medicines which mimic the pancreatic hormone amylin that is co-secreted with insulin. It is being developed as a standalone treatment, and in combination with the company's other GLP-1 drug MET-097i. The two hormones combined suppress hunger, help control patients' blood glucose. Metsera's shares, which touched $35.19 in early trading, were up 5% at midday. The first wave of obesity drugs was based mainly on the gut hormone GLP-1, but drugmakers are looking for medicines that target other hormones or help preserve muscle while losing fat for their next generation of drugs. Data from Novo Nordisk's experimental drug CagriSema, which was touted to be the successor of its blockbuster obesity drug Wegovy, has so far fallen below investor expectations. Data from Metsera's 80-patient study showed that its drug has a half life of about 19 days, supporting once-a-month dosing. This compares to the five to seven days for Lilly's Zepbound and Novo's Wegovy that are taken weekly, said Evercore ISI analyst Umer Raffat. The so-called half life of a drug refers to the time it takes for the initial dose of the medicine to decrease by half in a patient's body. It helps determine how frequently a drug should be taken to achieve benefits. Drugmaker AstraZeneca (AZN.L), opens new tab is also testing an amylin-based obesity drug in early trials.


Scottish Sun
an hour ago
- Scottish Sun
The 52p herb that could help prevent Alzheimer's – plus 3 other ways it can benefit your health
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) KNOWN for its strong, pine-like flavour and its use in various dishes, rosemary has a lot more going for it than its scent and taste. The popular herb is starting to gain recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. Sign up for Scottish Sun newsletter Sign up 2 Rosemary has been shown to benefit the brain in several ways Credit: Getty And research published this year suggests it could even help in the fight against Alzheimer's disease - the leading cause of dementia worldwide. Rosemary has previously been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary to sharpen concentration and recall, says Dipa Kamdar, senior lecturer in pharmacy practice at Kingston University. Writing for The Conversation, she explains: "Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory takes compared to those in an unscented environment." There are several ways rosemary benefits the brain, says Kamdar. Firstly, it stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties, with some studies suggesting its aroma can reduce anxiety and improve sleep - lower stress means better focus and memory retention. Kamdar adds: "Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age." And rosemary's antioxidants may also help protect brain cells from damage caused by oxidative stress - which is a major factor in cognitive decline. Kamdar says: " Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease." Five simple tests that could indicate dementia What are rosemary's benefits beyond brain health? 2 Rosemary may aid digestion by stimulating the liver to produce bile Credit: Getty As well as boosting brain health, studies suggest rosemary may aid digestion by stimulating the liver to produce bile, which helps the body digest fat. In a study with mice, it was shown to reduce inflammation in the digestive tract, potentially aiding in the management of IBS and other inflammatory bowel ailments. And rosemary supplementation may also positively impact the gut microbiota, increasing beneficial bacteria like Bifidobacterium and Bacteroidetes, while reducing harmful bacteria like Escherichia coli. Rosemary may also be able to improve immune function. Some studies, particularly in vitro and animal models, suggest that rosemary and its active compounds, like carnosic acid and rosmarinic acid, can influence immune function. Other studies have shown rosemary may promote immune cell activity, such as increasing antibody production or enhancing the activity of immune cells like dendritic cells. Finally, rosemary could prevent certain cancers. Rosemary has been proven to display powerful anticancer efficacy in numerous cancers, including lung, prostate, liver, and breast. Carnosic acid appears to be the plant's primary anticancer component, as it was found in one study to exhibit antiproliferative effects in cancer cells.


The Sun
2 hours ago
- The Sun
I was traumatised when I was plagued by grim ‘fart burps' months after taking Mounjaro fat jabs
HANNAH Metcalfe caught a whiff of something very unpleasant and felt her cheeks flush red. "It's him, he's farted!" she squealed, pointing at one of the burly blokes standing nearby her at the New Year's party. But the taste in her mouth told a very different - truthful - story. 6 6 6 In fact, the 31-year-old knew the rotten egg smell had come from one of her own burps - an embarrassing side effect of taking weight loss jabs. Around three months after she first started using them, she began having these horrific burps that her friends and family would often compare to the stench of farts, much to her embarrassment. But, despite the embarrassing side effect, Hannah says the weight loss jabs were well worth the trouble, and has gone on to drop an incredible 5st 11lbs. At her heaviest, Hannah weighed 16st 7lbs and was struggling with health concerns as a result, including back pain and muscular issues. Ashamed by her size, she refused to pose for pictures during her own 30th birthday trip to Las Vegas, and couldn't properly enjoy the 'once in a lifetime' holiday with her mum. At her wits end, and having had no luck with diets like Slimming World, fasting and juicing,she decided to try weight loss jab Mounjaro last September. But while the weight started to drop off of her, the unpleasant side effect reared its head. When people noticed the "rotten eggs" stench, Hannah was forced to blame other people for breaking wind or pretended to wonder who was responsible. 'I'm incredibly fortunate that I've had a great experience – but I did experience some of the weirder side effects,' the accounts assistant, from Manchester, tells Sun Health. 'I started having sulphur, rotten egg-like burps after 12 weeks. 'They didn't have any pattern and just happened randomly, no matter what I ate. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies 'I remember them being really warm in my throat, and the smell was horrendous. 'Usually people would think that I'd passed wind – and weirdly that was less embarrassing to admit! 'I kept quite private [during my weight loss] as it was really embarrassing.' Hannah – who worked with weight loss program Juniper – also experienced constipation and dizzy spells, but kept a close eye on what she was consuming throughout her weight loss. She said: 'I knew some of the side effects might occur from the information Juniper had provided me with. 'If I experienced something that I hadn't read or seen online, my health coach provided me tips and information on what was happening, which I really liked. What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin. 'I never felt worried about the side effects I was experiencing. 'I was aware of the [potential] sulphur burps, so when they started, I wasn't panicked.' Hannah was a size 24 when she started taking Mounjaro and 'unbelievably unhappy' with how she looked. She said: 'I've always been focused on body confidence and not being ashamed of how I looked, but so many more external factors started to nag in my head. 'I had lower back pain, and regardless of so many scans and doctors appointments to find a root cause, it all fell down to my weight, and the deterioration of my muscles not being able to support my weight. 'It was a really big shock to the system. 6 'I went on the holiday with my mum and I don't have any photos of myself enjoying it, because I hated having photos taken – I still regret that, but my body confidence was shot and my mental health with it too.' She eased her way into the medication, starting on a low dose and building up – and has seen incredible results. Despite any strange side effects, Hannah says it has all been well worth it. She said: 'Thankfully I didn't experience the really bad side effects that some people experience, such as sickness, which I'm grateful for – but I think that even if I did, I would still recommend it. 'I actually recommended it to my partner, and he started taking the medication and has successfully lost weight, and he's experienced absolutely no side effects. 'I've lost 40cm off of my waist and feel amazing now. 'I constantly take photographs of myself and send them to my mum to show her how good I look in my new outfits. 'I also just booked a beach holiday so I can wear a bikini and get great photos of myself and how much I've lost. 'I'm not ashamed to look in the mirror, or try on clothes in a shop [anymore]. 'But it has been a learning curve, no longer seeing myself in a big body and shrouding myself in large clothes to hide myself. 'I still find it challenging to wear fitted clothes, but when I do, people notice and compliment me and it makes me feel amazing – and worth all the money I spent and the side effects I experienced.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.